5-hydroxytryptophan has been researched along with Dyskinesia, Medication-Induced in 7 studies
5-Hydroxytryptophan: The immediate precursor in the biosynthesis of SEROTONIN from tryptophan. It is used as an antiepileptic and antidepressant.
5-hydroxytryptophan : A tryptophan derivative that is tryptophan substituted by a hydroxy group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Progress in the treatment of action myoclonus is especially noteworthy and has led to the implication of serotonin deficit in the pathophysiology of this syndrome." | 1.26 | New approaches in the management of hyperkinetic movement disorders. ( Fahn, S, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Meloni, M | 1 |
| Puligheddu, M | 1 |
| Sanna, F | 1 |
| Cannas, A | 1 |
| Farris, R | 1 |
| Tronci, E | 2 |
| Figorilli, M | 1 |
| Defazio, G | 1 |
| Carta, M | 2 |
| Lisci, C | 1 |
| Stancampiano, R | 1 |
| Fidalgo, C | 1 |
| Collu, M | 1 |
| Devoto, P | 1 |
| Sedel, F | 1 |
| Ribeiro, MJ | 1 |
| Remy, P | 1 |
| Blau, N | 1 |
| Saudubray, JM | 1 |
| Agid, Y | 1 |
| Nasrallah, HA | 2 |
| Smith, RE | 2 |
| Dunner, FJ | 2 |
| McCalley-Whitters, M | 2 |
| Maj, J | 1 |
| Rogóz, Z | 1 |
| Dlaboga, D | 1 |
| Dziedzicka-Wasylewska, M | 1 |
| Fahn, S | 1 |
3 trials available for 5-hydroxytryptophan and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Efficacy and safety of 5-Hydroxytryptophan on levodopa-induced motor complications in Parkinson's disease: A preliminary finding.
Topics: 5-Hydroxytryptophan; Animals; Antiparkinson Agents; Cross-Over Studies; Dose-Response Relationship, | 2020 |
Serotonin precursor effects in tardive dyskinesia.
Topics: 5-Hydroxytryptophan; Adult; Aged; Carbidopa; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle | 1982 |
Pharmacologic probes of neurotransmitter systems in tardive dyskinesia: implications for clinical management.
Topics: 5-Hydroxytryptophan; Adult; Aged; Choline; Clinical Trials as Topic; Dihydroxyphenylalanine; Dopamin | 1986 |
4 other studies available for 5-hydroxytryptophan and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
5-Hydroxy-tryptophan for the treatment of L-DOPA-induced dyskinesia in the rat Parkinson's disease model.
Topics: 5-Hydroxytryptophan; Adrenergic Agents; Animals; Caudate Nucleus; Disease Models, Animal; Dopamine; | 2013 |
Dihydropteridine reductase deficiency: levodopa's long-term effectiveness without dyskinesia.
Topics: 5-Hydroxytryptophan; Adult; Antidepressive Agents, Second-Generation; Dopamine Agents; Drug Combinat | 2006 |
Pharmacological effects of milnacipran, a new antidepressant, given repeatedly on the alpha1-adrenergic and serotonergic 5-HT2A systems.
Topics: 5-Hydroxytryptophan; Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Aggression; Amphetamin | 2000 |
New approaches in the management of hyperkinetic movement disorders.
Topics: 5-Hydroxytryptophan; Carbidopa; Chorea; Dyskinesia, Drug-Induced; Humans; Movement Disorders; Myoclo | 1977 |